{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:29Z","timestamp":1786995029299,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["401032\/2016\\u20137"],"award-info":[{"award-number":["401032\/2016\\u20137"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2019\/02730\\u20132"],"award-info":[{"award-number":["2019\/02730\\u20132"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.neuroscience.2022.10.025","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T12:24:14Z","timestamp":1667305454000},"page":"125-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Meta-Chlorophenylpiperazine-Induced Behavioral Changes in Obsessive-Compulsive Disorder Research: A Systematic Review of Rodent Studies"],"prefix":"10.1016","volume":"507","author":[{"given":"J\u00e9ssica Fernandes","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Mitsuko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinete da Silva","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Ribeiro","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6137","key":"10.1016\/j.neuroscience.2022.10.025_b0005","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1234733","article-title":"Repeated cortico-striatal stimulation generates persistent OCD-like behavior","volume":"340","author":"Ahmari","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0010","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/NDT.S62785","article-title":"Animal models of obsessive\u2013compulsive disorder: utility and limitations","volume":"11","author":"Alonso","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0015","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0960-894X(01)00721-1","article-title":"Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo{[}c, f]isoxazolo{[}2,3-a]azepine derivatives: A novel series of 5-HT2A\/2C receptor antagonists. Part 1","volume":"12","author":"Andr\u00e9s","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1461145798001151","article-title":"Gender Differences in m-CPP Challenge Tests in Healthy Volunteers","volume":"1","author":"Arat\u00f3","year":"1998","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0091-3057(94)90077-9","article-title":"Functional and biochemical evidence for altered serotonergic function in the fawn-hooded rat strain","volume":"49","author":"Aulakh","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"issue":"16","key":"10.1016\/j.neuroscience.2022.10.025_b0035","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/00001756-199511000-00013","article-title":"The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain","volume":"6","author":"Baumann","year":"1995","journal-title":"NeuroReport"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.10.025_b0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0893-133X(00)00221-9","article-title":"1-(m-Chlorophenyl) piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain","volume":"24","author":"Baumann","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.10.025_b0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.kjms.2012.11.003","article-title":"Effects of agomelatine in a murine model of obsessive-compulsive disorder: Interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam","volume":"29","author":"Bhutada","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0924-9338(99)00224-2","article-title":"Gender-related clinical differences in obsessive-compulsive disorder","volume":"14","author":"Bogetto","year":"1999","journal-title":"European Psychiatry"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.10.025_b0055","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0028-3908(99)00191-4","article-title":"Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat","volume":"39","author":"Bristow","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-1781(98)00029-8","article-title":"Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive\u2013compulsive disorder (OCD): behavioral and biological results","volume":"79","author":"Broocks","year":"1998","journal-title":"Psychiatry Res"},{"issue":"4\u20135","key":"10.1016\/j.neuroscience.2022.10.025_b0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00008877-199408000-00008","article-title":"Dissociation of serotoninergic regulation of anxiety and ethanol self-administration - a study with mCPP","volume":"5","author":"Buczek","year":"1994","journal-title":"Behavioral Pharmacology"},{"issue":"6137","key":"10.1016\/j.neuroscience.2022.10.025_b0070","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.1232380","article-title":"Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors","volume":"340","author":"Burgui\u00e8re","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1990.01810180011002","article-title":"Age at onset of selected mental disorders in five community populations","volume":"47","author":"Burke","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0080","series-title":"Animal Models for OCD Research","first-page":"55","author":"Chamberlain","year":"2021"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1988.01800260095012","article-title":"Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects","volume":"45","author":"Charney","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12993-021-00177-x","article-title":"Distinct behavioral traits and associated brain regions in mouse models for obsessive-compulsive disorder","volume":"17","author":"Chen","year":"2021","journal-title":"Behavioral and Brain Functions"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.10.025_b0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jpsychires.2007.09.001","article-title":"Hypersensitivity of 5-HT2 receptors in OCD patients: an increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo","volume":"42","author":"de Leeuw","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41398-021-01448-x","article-title":"Lost in translation: no effect of repeated optogenetic cortico-striatal stimulation on compulsivity in rats","volume":"11","author":"de Oliveira","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(93)90530-U","article-title":"Shock-induced ultrassonic vocalization in young-adult rats - A model for testing putative anti-anxiety drugs","volume":"249","author":"de Vry","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.10.025_b0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2018.0930","article-title":"Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review","volume":"75","author":"Dougherty","year":"2018","journal-title":"Jama Psychiatry"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0893-133X(98)00070-0","article-title":"Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain","volume":"20","author":"Eriksson","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0893-133X(00)00178-0","article-title":"Low versus standard dose mCPP challenge in obsessive-compulsive patients","volume":"24","author":"Erzegovesi","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF02246164","article-title":"The role of the 5-HT2A and 5.HT2c receptors in the stimulus effects of m-chlorophenylpiperazine","volume":"119","author":"Fiorella","year":"1995","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.10.025_b0130","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0024-3205(03)00422-3","article-title":"Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety","volume":"73","author":"Gatch","year":"2003","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2012.08.081","article-title":"Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder","volume":"528","author":"Georgiadou","year":"2012","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130050622","article-title":"Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action","volume":"137","author":"Gommans","year":"1998","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-3223(94)00235-U","article-title":"m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation","volume":"38","author":"Goodman","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","article-title":"Harmonizing the neurobiology and treatment of obsessive-compulsive disorder","volume":"178","author":"Goodman","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-4328(02)00404-7","article-title":"m-CPP-induced self-grooming is mediated by 5-HT 2C receptors","volume":"142","author":"Graf","year":"2003","journal-title":"Behavioral Brain Research"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00737-021-01187-4","article-title":"Symptom fluctuation over the menstrual cycle in anxiety disorders, PTSD, and OCD: a systematic review","volume":"25","author":"Green","year":"2022","journal-title":"Archives of Women's Mental Health"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000079970","article-title":"Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan","volume":"50","author":"Gross-Isseroff","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.10.025_b0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-3223(89)90217-5","article-title":"1-(m-Chlorophenyl) piperazine (mCPP) interactions with neurotransmitter receptors in the human brain","volume":"25","author":"Hamik","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004583-199501000-00009","article-title":"Demographic and clinical features of obsessive-compulsive disorder in children and adolescents","volume":"34","author":"Hanna","year":"1995","journal-title":"Academy of Child and Adolescent Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neuroscience.2022.10.025_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2006.09.042","article-title":"Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: A comparison with diazepam and buspirone","volume":"553","author":"Harada","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(91)90113-4","article-title":"Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder","volume":"36","author":"Hollander","year":"1991","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-1781(90)90073-E","article-title":"Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects","volume":"33","author":"Kahn","year":"1990","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.10.025_b0195","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0006-3223(91)90184-N","article-title":"m-Chlorophenylpiperazine as a probe of serotonin function","volume":"30","author":"Kahn","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02245708","article-title":"Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioral-responses to mCPP","volume":"113","author":"Kennedy","year":"1993","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0014-2999(89)90252-5","article-title":"Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists","volume":"164","author":"Kennett","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.neuroscience.2022.10.025_b0215","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0028-3908(94)90133-3","article-title":"Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C 2B receptor function","volume":"33","author":"Kennett","year":"1994","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0306-4530(00)00048-2","article-title":"Neuroendocrine and behavioral responses to mCPP in obsessive\u2013compulsive disorder","volume":"26","author":"Khanna","year":"2001","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.10.025_b0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00213-008-1241-5","article-title":"Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder","volume":"200","author":"Kontis","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pbb.2013.01.006","article-title":"Ritualistic chewing behavior induced by mCPP in rat is an animal model of obsessive compulsive disorder","volume":"104","author":"Kreiss","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0235","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4088\/JCP.v66n0404","article-title":"Female reproductive cycle and obsessive-compulsive disorder","volume":"66","author":"Labad","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0240","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/da.20332","article-title":"Gender differences in obsessive-compulsive symptom dimensions","volume":"25","author":"Labad","year":"2008","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.169.1.101","article-title":"Obsessive compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences","volume":"169","author":"Lensi","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0250","series-title":"Models of mental disorders: a new comparative psychiatry","author":"McKinney","year":"1988"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0255","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/archpsyc.1969.01740200112015","article-title":"Animal model of depression: I. Review of evidence: Implications for research","volume":"21","author":"McKinney","year":"1969","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.10.025_b0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00008877-199708000-00008","article-title":"Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats","volume":"8","author":"Meert","year":"1997","journal-title":"Behav Pharmacol"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0270","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12051","article-title":"Cannabidiol reverses the mCPP-induced increase in marble-burying behavior","volume":"28","author":"Nardo","year":"2014","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0275","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2013.01.005","article-title":"5-HT2C receptor involvement in the control of persistence in the Reinforced Spatial Alternation animal model of obsessive-compulsive disorder","volume":"243","author":"Papakosta","year":"2013","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.10.025_b0280","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive\u2013compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10.1016\/j.neuroscience.2022.10.025_b0285","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0006-2952(84)90424-6","article-title":"Serotonin-releasing effects of substituted piperazines in vitro","volume":"33","author":"Pettibone","year":"1984","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(93)90272-F","article-title":"A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to iv mCPP","volume":"33","author":"Pigott","year":"1993","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.10.025_b0295","first-page":"375","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatric Clinics"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0300","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential-effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic-neurons on the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.neuroscience.2022.10.025_b0305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2009.02.041","article-title":"1-(m-Chlorophenyl) piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT2A receptors: Proposal of a modified rodent antidepressant assay","volume":"608","author":"Rajkumar","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0310","first-page":"10","article-title":"Epidemiology of obsessive compulsive disorder","volume":"51","author":"Rasmussen","year":"1990","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2021.152223","article-title":"Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials","volume":"106","author":"Reid","year":"2021","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0320","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbr.2015.06.036","article-title":"Rats with differential self-grooming expression in the elevated plus-maze do not differ in anxiety-related behaviors","volume":"292","author":"Reimer","year":"2015","journal-title":"Behavioral Brain Research"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuropharm.2017.12.015","article-title":"Fear extinction in an obsessive-compulsive disorder animal model: Influence of sex and estrous cycle","volume":"131","author":"Reimer","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuron.2019.01.046","article-title":"Obsessive-compulsive disorder: puzzles and prospects","volume":"102","author":"Robbins","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fpsyt.2017.00089","article-title":"Behavioral effects of a novel Benzofuranyl-Piperazine serotonin-2c receptor agonist suggest a Potential Therapeutic application in the Treatment of Obsessive-Compulsive Disorder","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0340","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.07.044","article-title":"The light switch-off response as a putative rodent test of innate fear","volume":"334","author":"Saito","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0345","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41593-021-00806-8","article-title":"Considering sex as a biological variable will require a global shift in science culture","volume":"24","author":"Shansky","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0350","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neubiorev.2017.05.029","article-title":"A review of the role of serotonin system genes in obsessive-compulsive disorder","volume":"80","author":"Sinopoli","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive\u2013compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.10.025_b0360","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1037\/0735-7044.112.6.1475","article-title":"Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)","volume":"112","author":"Szechtman","year":"1998","journal-title":"Behav Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.10.025_b0365","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/pr.119.017772","article-title":"The psychopharmacology of obsessive-compulsive disorder: a preclinical roadmap","volume":"72","author":"Szechtman","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.10.025_b0370","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00213-005-0032-5","article-title":"Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: The role of the serotonin transporter","volume":"181","author":"Troelsen","year":"2005","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.10.025_b0375","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.biopsych.2005.02.020","article-title":"Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology","volume":"57","author":"Tsaltas","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.10.025_b0380","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-013-2976-1","article-title":"Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD)","volume":"227","author":"Tucci","year":"2013","journal-title":"Psychopharmacology"},{"issue":"18","key":"10.1016\/j.neuroscience.2022.10.025_b0385","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1007\/s00213-014-3505-6","article-title":"Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD)","volume":"231","author":"Tucci","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0390","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2014.11.017","article-title":"5-HT2A\/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD)","volume":"279","author":"Tucci","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0395","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00048670903393639","article-title":"Obsessive-compulsive disorder in postmenopausal women: prevalence, clinical features, and comorbidity","volume":"44","author":"Uguz","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"issue":"7156","key":"10.1016\/j.neuroscience.2022.10.025_b0400","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0405","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4088\/JCP.v58n0709","article-title":"Obsessive\u2013compulsive disorder in pregnancy, the puerperium, and the premenstruum","volume":"58","author":"Williams","year":"1997","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.10.025_b0410","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0278-5846(86)90051-5","article-title":"Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case","volume":"10","author":"Willner","year":"1986","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.10.025_b0415","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1568007033482698","article-title":"Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders","volume":"2","author":"Wood","year":"2003","journal-title":"Current Drug Targets-CNS & Neurological Disorders"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.10.025_b0420","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.pbb.2004.05.003","article-title":"Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats","volume":"78","author":"Yamauchi","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2022.10.025_b0425","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0006-3223(87)90199-5","article-title":"Obsessive-Compulsive Disorder: Psychobiological Approaches to Diagnosis, Treatment, and Pathophysiology","volume":"22","author":"Zohar","year":"1987","journal-title":"Biol Psychiatry"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222005425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222005425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:45:48Z","timestamp":1777556748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222005425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":85,"alternative-id":["S0306452222005425"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.10.025","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Chlorophenylpiperazine-Induced Behavioral Changes in Obsessive-Compulsive Disorder Research: A Systematic Review of Rodent Studies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}